Data for (Study ST004276)
(Analysis AN007115)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 |
|---|---|---|
| 1-MG_L | 1.0584 | 0.9611 |
| 2-HIBA_M | NA | NA |
| 3-HBA (d)_M | 1.0220 | 0.9780 |
| 3-HIBA_M | 1.0570 | 0.9430 |
| 3M2OV(KIV)_M | 0.9678 | 1.0322 |
| 4M2OV(KIC)_M | 1.0191 | 0.9809 |
| Acetate_M | 1.0389 | 0.9611 |
| Acetate_P | 1.0623 | 0.9585 |
| Acetone_M | 1.4674 | 0.5326 |
| ADP_P | 1.0059 | 0.9961 |
| Ala_M | 0.9611 | 1.0389 |
| Ala_P | 0.7986 | 1.1343 |
| AMP_P | 1.3237 | 0.7842 |
| Arg_M | NA | NA |
| Asn_M | NA | NA |
| Asn_P | 0.8198 | 1.1201 |
| Asp_M | NA | NA |
| Asp_P | 1.0196 | 0.9869 |
| ATP_P | 0.9381 | 1.0413 |
| Cho_M | 1.1612 | 0.8388 |
| Cho_P | 1.0303 | 0.9798 |
| Citrate_M | 0.9868 | 1.0132 |
| Cr_P | 0.9723 | 1.0184 |
| Cr(+Tyr)_M | NA | NA |
| Cysteine_M | 1.0439 | 0.9561 |
| Cystine_M | NA | NA |
| FA(CH2)n_L | 1.0118 | 0.9921 |
| FAs in TG+GPL+Echol_L | 1.0048 | 0.9968 |
| Fchol_L | 1.0107 | 0.9929 |
| FFAs+Faz in 1-MG_L | 1.0637 | 0.9576 |
| Formate_M | 0.9558 | 1.0442 |
| Formate_P | 1.0254 | 0.9831 |
| Gln_M | NA | NA |
| Gln_P | 0.8460 | 1.1027 |
| Glucose_M | NA | NA |
| Glucose_P | NA | NA |
| Glu_M | NA | NA |
| Glu_P | 0.9856 | 1.0096 |
| Glycerol_P | 0.8369 | 1.1087 |
| Gly_M | 1.0187 | 0.9813 |
| Gly_P | 0.7638 | 1.1574 |
| GPC_P | 1.0705 | 0.9530 |
| GPLs_L | 1.0386 | 0.9743 |
| GSH_P | 1.0526 | 0.9649 |
| His_M | NA | NA |
| Ile_M | NA | NA |
| Ile_P | 0.8494 | 1.1004 |
| Inosine_P | 2.3314 | 0.1124 |
| Lac_M | 0.9695 | 1.0305 |
| Lac_P | 0.9408 | 1.0395 |
| LA_L | 0.9689 | 1.0207 |
| Leu_M | NA | NA |
| Leu_P | 0.9743 | 1.0171 |
| Lys_M | NA | NA |
| Met_M | NA | NA |
| m-Ino_P | 0.9468 | 1.0355 |
| MUFAs_L | 1.0405 | 0.9730 |
| NAD+_P | 0.9008 | 1.0662 |
| PCho_P | 0.9410 | 1.0393 |
| PCr_P | 0.9980 | 1.0014 |
| Phe_M | NA | NA |
| Plasmalogens_L | 1.0932 | 0.9379 |
| Pro_M | NA | NA |
| Pro_P | 1.0354 | 0.9764 |
| PtdCho_L | 1.0293 | 0.9805 |
| PUFAs_L | 1.0378 | 0.9748 |
| PUFAs w/ LA_L | 1.0343 | 0.9771 |
| Pyr_M | NA | NA |
| PyroGlu_M | 1.0242 | 0.9758 |
| SM_L | 1.1282 | 0.9145 |
| SMs+LysoPC_L | 1.2469 | 0.8766 |
| Succinate_P | 0.9399 | 1.0400 |
| Succ(+PyroGlu)_M | 1.0233 | 0.9767 |
| Tau_P | 1.1292 | 0.9138 |
| Tchol_L | 1.0429 | 0.9714 |
| Thr_M | NA | NA |
| Thr_P | 0.7852 | 1.1432 |
| Trp_M | NA | NA |
| Tyr_M | NA | NA |
| Tyr_P | 0.9942 | 1.0039 |
| UDP-GlcNAc_P | 0.6080 | 1.2613 |
| UFAs_L | 1.0407 | 0.9729 |
| Val_M | NA | NA |
| Val_P | 0.9733 | 1.0178 |
| w3 FA_L | 0.9847 | 1.0102 |
| w3+w6 FA _L | 1.0278 | 0.9815 |
Factors:
| F1 | Sample source:hASCs | Treatment:Osteogenic conditions |
| F2 | Sample source:hASCs | Treatment:Proliferation conditions |
